Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Breast 2Sarcoma 1Myeloid 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 47Osteosarcoma 15Dendritic Cell Sarcoma, Interdigitating 12Bone Neoplasms 11Rhabdomyosarcoma 9Gastrointestinal Stromal Tumors 8Sarcoma, Ewing 5Melanoma 5Sarcoma, Kaposi 4Recurrence 4Neurofibrosarcoma 4Neoplasms 4Liposarcoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Alveolar Soft Part 3Ovarian Neoplasms 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sarcoma, Synovial 2Pancreatic Neoplasms 2Neurofibromatosis 1 2Neuroblastoma 2Medulloblastoma 2Lung Neoplasms 2Leiomyosarcoma 2Leiomyoma 2Hodgkin Disease 2

Interventions

montelukast 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Inflammation × Sarcoma × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡